Pediatric Research
MIS-C Diagnosed More Often in Black, Hispanic Children
Researchers from The George Washington University
July 14, 2021
Researchers from The George Washington University
Two phase 3, placebo-controlled studies suggest the oral Janus kinase (JAK) inhibitor upadacitinib is effective for moderate-to-severe atopic dermatitis (AD),
A childhood diagnosis of atopic dermatitis was associated with lower attainment of secondary education but not higher education, according to a population-based
Exposure to antibiotics in utero and during the first year of life is associated with an increased risk for atopic
Importance Propranolol has become the first-line therapy for problematic infantile hemangiomas (IHs) that require systemic therapy. However, different adverse events
A U.S.-wide ban on teen use of tanning beds would prevent thousands of cases of skin cancer and save millions
Some patients with infantile hemangioma ulceration may have prolonged healing times, and larger hemangioma size may be a poor prognostic factor for
April 12, 2021 Keshav Patel, MS4 , Bernard A Cohen, MD Contemporary PEDS Journal, Vol 38 No 4, Volume 38,
Secukinumab proved highly effective at improving skin symptoms and quality of life in 6- to 17-year-old patients with moderate to
Copyright © 2024, A4M. All trademarks, registered or unregistered, are the property of their respective owners.
